These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 31852635)

  • 1. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.
    Sarin SK; Kumar M; Eslam M; George J; Al Mahtab M; Akbar SMF; Jia J; Tian Q; Aggarwal R; Muljono DH; Omata M; Ooka Y; Han KH; Lee HW; Jafri W; Butt AS; Chong CH; Lim SG; Pwu RF; Chen DS
    Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):167-228. PubMed ID: 31852635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing epidemiology of liver diseases in the Asia-Pacific region.
    Wong MCS; Huang JLW; George J; Huang J; Leung C; Eslam M; Chan HLY; Ng SC
    Nat Rev Gastroenterol Hepatol; 2019 Jan; 16(1):57-73. PubMed ID: 30158570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effective options for the prevention and management of gastrointestinal and liver disease in the Asia-Pacific region.
    Roberts-Thomson IC; Lung T
    J Gastroenterol Hepatol; 2018 Jan; 33(1):121-127. PubMed ID: 28833619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030.
    Ou TY; Huy LD; Mayne J; Shih CL; Mai Xuan H; Thi Hong Nguyen N; Nguyen Hoai L; Thi My Bui L; Chang YM; Abdi AA; Hsu SC; Lin HJ; Huang CC
    J Infect Public Health; 2024 Jul; 17(7):102443. PubMed ID: 38838606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
    Chitturi S; Farrell GC; George J
    J Gastroenterol Hepatol; 2004 Apr; 19(4):368-74. PubMed ID: 15012772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic hepatitis C in Asia: when East meets West.
    Yu ML; Chuang WL
    J Gastroenterol Hepatol; 2009 Mar; 24(3):336-45. PubMed ID: 19335784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.
    Paik JM; Golabi P; Younossi Y; Mishra A; Younossi ZM
    Hepatology; 2020 Nov; 72(5):1605-1616. PubMed ID: 32043613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: review of disease progression.
    Lin X; Robinson NJ; Thursz M; Rosenberg DM; Weild A; Pimenta JM; Hall AJ
    J Gastroenterol Hepatol; 2005 Jun; 20(6):833-43. PubMed ID: 15946129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
    Alberts CJ; Clifford GM; Georges D; Negro F; Lesi OA; Hutin YJ; de Martel C
    Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):724-735. PubMed ID: 35576953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease burden and costs from excess alcohol consumption, obesity, and viral hepatitis: fourth report of the Lancet Standing Commission on Liver Disease in the UK.
    Williams R; Alexander G; Armstrong I; Baker A; Bhala N; Camps-Walsh G; Cramp ME; de Lusignan S; Day N; Dhawan A; Dillon J; Drummond C; Dyson J; Foster G; Gilmore I; Hudson M; Kelly D; Langford A; McDougall N; Meier P; Moriarty K; Newsome P; O'Grady J; Pryke R; Rolfe L; Rice P; Rutter H; Sheron N; Taylor A; Thompson J; Thorburn D; Verne J; Wass J; Yeoman A
    Lancet; 2018 Mar; 391(10125):1097-1107. PubMed ID: 29198562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards achieving viral hepatitis B and C elimination in the Asia and Pacific region: Results from modelling and global reporting.
    Le LV; Blach S; Rewari B; Chan P; Fuqiang C; Ishikawa N; Sharma M; Mangadan-Konath N; Razavi H; Low-Beer D; Razavi-Shearer D
    Liver Int; 2022 Aug; 42(9):1930-1934. PubMed ID: 34894047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of liver failure in Asia-Pacific region.
    Jindal A; Sarin SK
    Liver Int; 2022 Aug; 42(9):2093-2109. PubMed ID: 35635298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the epidemiological trends of primary liver cancer in the Asia-Pacific region.
    Danpanichkul P; Suparan K; Sukphutanan B; Kaeosri C; Tothanarungroj P; Sirimangklanurak S; Kalligeros M; Polpichai N; Pang Y; Wijarnpreecha K; Sripongpun P; Chamroonkul N; Nguyen MH; Liangpunsakul S; Piratvisuth T; Kaewdech A
    Sci Rep; 2024 Aug; 14(1):19544. PubMed ID: 39174722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
    Kao JH
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Communities living with hepatitis must be central to the response to liver diseases in the Asia-Pacific region.
    Wingrove C; Wang S; Ninburg M; Agustian E; Lee D
    Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):107-109. PubMed ID: 31852634
    [No Abstract]   [Full Text] [Related]  

  • 18. Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment.
    Wong VW; Chan WK; Chitturi S; Chawla Y; Dan YY; Duseja A; Fan J; Goh KL; Hamaguchi M; Hashimoto E; Kim SU; Lesmana LA; Lin YC; Liu CJ; Ni YH; Sollano J; Wong SK; Wong GL; Chan HL; Farrell G
    J Gastroenterol Hepatol; 2018 Jan; 33(1):70-85. PubMed ID: 28670712
    [No Abstract]   [Full Text] [Related]  

  • 19. Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences from 1990-2019: A DALY-based analysis of the Global Burden of Disease 2019 study.
    Choi S; Kim BK; Yon DK; Lee SW; Lee HG; Chang HH; Park S; Koyanagi A; Jacob L; Dragioti E; Radua J; Shin JI; Kim SU; Smith L
    Clin Mol Hepatol; 2023 Apr; 29(2):433-452. PubMed ID: 36597018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public health measures to control hepatitis B virus infection in the developing countries of the Asia-Pacific region.
    Chen DS
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E7-10. PubMed ID: 10921374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.